Skip to content

Lilly

Login|Contact us|Worldwide|Sitemap|

  • Home
  • About Us
  • Responsibility
  • Products
  • Research & Development
  • Investors
  • Careers
  • News
Home > News > Media Kits > The Lilly TB Drug Discovery Initiative Media Kit

The Lilly TB Drug Discovery Initiative

  • News
  • Corporate News
  • Financial News
  • Product News
  • Speeches
  • Media Contacts
  • Press Release Archives
  • Media Kits
    • Alimta®
    • Byetta®
    • Bone and Osteoporosis Information
    • Cymbalta®
    • Effient™
    • Gemzar®
    • Global Day of Service
    • Healthy You
    • Health Care Disparities
    • Lilly Oncology On Canvas
    • Medicaid Partnerships
    • Multiple Drug Resistant Tuberculosis
    • Strattera®
    • Symbyax™
    • Xigris®
    • Zyprexa®
  • Photos
    • Logos
    • Locations
    • People
    • Products
  • Helpful Links

Media Kit Materials

  • TB Drug Discovery press release - October 7, 2008 (PDF)
  • Background on the Acquired Compounds (PDF)
  • Initiative Participants (PDF)
  • Initiative Question and Answer (PDF)
  • Initiative Facts at a Glance - October 7, 2008 (PDF)
  • Initiative Steering Committee (PDF)
  • Initiative Board of Advisors (PDF)
  • Gail Cassell, Ph.D. (PDF)
  • Carole Heilman, Ph.D. (PDF)
  • Steve Reed, Ph.D. (PDF)
  • Initiative Logo (PDF)

Important Note: You must have Acrobat Reader version 4.0 or higher installed to view these files. If you have an earlier version installed, an update is available from the Adobe Acrobat Reader download site.

Copyright © Eli Lilly and Company. All rights reserved.

Careers | Terms of Use | Privacy | For Suppliers | Sitemap | Contact us